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Figure 1
Positional cloning of COQ6 mutations in individuals with NS and SND. (A) lod score profile across the human genome in affected children from 14 
consanguineous kindred with SRNS. Parametric heterogeneity lod (HLOD) scores are plotted against human chromosomal mapping positions, 
concatenated from p-ter (left) to q-ter (right). (B) Within the SRNS2 locus, haplotypes from 250k SNP analysis are shown for 3 of the 7 families 
with homozygosity at the SRNS2 locus. Alleles are colored light green (AA), dark green (BB), and red (AB). (C) The 32 genes within the SRNS2 
locus; 3 genes preferentially expressed in kidney podocytes are underlined. Mutations were found in COQ6. Transcriptional direction is indicated 
by < or >. (D) COQ6 extends over 13.2 kb and contains 12 exons (boxes). (E) Exon structure of COQ6 cDNA. Arrows indicate relative positions of 
mutations (see G). Positions of peptides for antibody generation are shown in yellow. (F) Domain structure of COQ6 protein. Extent of the mono-
oxygenase domain is shown in relation to encoding exon position (E). (G) 6 different COQ6 mutations in 7 families with SRNS. Family number 
and amino acid change (see Table 1) are given above sequence traces. Arrows denote positions of mutations in relation to exons and protein 
domains. For the 2 missense mutations, G255R and A363D, full conservation across evolution of altered amino acid residues is illustrated.
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Endogenous COQ6, COQ7, and COQ9 colocalize to cell processes and 






























COQ6 loss-of-function causes glomerular damage in human kidney and growth defects in yeast. (A–C) Renal histology in individuals revealed 
homozygous COQ6 mutation in A3331-21 FSGS, demonstrated by increased fibrosis (blue) in Trichrome-Masson staining (A), and in F1082-
21, demonstrated by excess PAS staining (red) (B). (C) Transmission electron microscopy for F1082 showed effacement of podocyte foot 
processes, resulting in a continuous electron-dense layer (arrowheads). Scale bars: 50 μm (A and B); 250 nm (C). (D and E) Functional test of 
human COQ6 mutations in yeast coq6-null mutants. (D) WT human COQ6 (hWT), but not mutations, rescued growth in yeast coq6-null mutants 
plated on a nonfermentable carbon source. Yeast cells harboring the indicated low-copy plasmids were cultured in SD-Ura, seeded to both SD-
Ura and YPG plate media, and incubated at 30°C for the times indicated. pSR1-1 contains the yeast COQ6 gene (18) and served as positive 
control. Empty vectors pRS316 and pRS426 served as negative controls. (E) WT human COQ6, but not mutations, rescued CoQ6 synthesis in 
yeast coq6-null mutants. CoQ6 content of each yeast coq6-null mutant harboring 1 of the designated plasmids was determined as described 
in Methods. Each CoQ6 measurement represents mean ± SD of 4 measurements from 2 independent samples. *P < 0.0005 versus negative 
control (99% confidence level). PQM and PRCM indicate low– and high–copy number plasmids, respectively.
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We  then  investigated expression of COQ6  in  the  inner  ear, 




























Transient exogenous expression of full-length human COQ6 isoform a into Cos-7 cells, HeLa cells, or murine podocyte cell lines. (A and B) 
GFP-labeled full-length human COQ6 isoform a (COQ6a-EmGFP) exogenously expressed in Cos-7 cells colocalized quantitatively with mito-
chondrial markers cytochrome c (A) and COXIV (B). (C–E) GFP-labeled full-length human COQ6 isoform a expressed exogenously in HeLa cells 
was detected by α–COQ6-TPEP2 upon immunofluorescence, thereby confirming specificity of the antibody (C). α–COQ6-TPEP2 detected an 
additional endogenous signal, which appeared to be localized in Golgi apparatus (C), as confirmed by double labeling with Golgi marker Golgin 
97 (D). α–COQ6-TPEP2 did not reveal any endogenous COQ6 expression in mitochondria (D and E). (F) GFP-labeled full-length human COQ6 
isoform a expressed exogenously in HeLa cells spared Golgi expression, as demonstrated with Giantin as a Golgi marker. (G) α–COQ6-TPEP2 
detected endogenous COQ6 in Golgi of a podocyte cell line, as marked by gm130, but not in mitochondria. Scale bars: 5 μm.
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COQ6 and COQ7 colocalize in rat podocytes to cell pro-
cesses and Golgi and in the inner ear to stria vascularis and 
spiral ligament cells. (A) In rat renal glomeruli (marked with 
an α-GLEPP1 antibody), α–COQ6-TPEP2 labeled podocyte 
cytoplasm and cell processes (left). COQ6 was expressed 
in podocytes, whose nuclei were marked with α-WT1 (mid-
dle), but not in mitochondria, marked with α-COXIV (right). 
(B) COQ6 (red) was located in podocyte cellular processes 
and in Golgi (marked with the trans-Golgi antibody TGN38), 
demonstrating colocalization (yellow). (C) COQ7 exhibited 
an expression pattern identical to that of COQ6 (see B). 
(D) There was full colocalization of COQ6 and COQ7 in 
podocyte cytoplasm, cell processes, and (by inference from 
B and C) Golgi. (E) COQ6 colocalized in podocyte cellular 
processes with podocin, another protein that, if mutated, 
causes SRNS. COQ6 showed additional expression more 
centrally in cell processes. (F) In cochlea (counterstained 
with rhodamin-phalloidin [Rh-Ph] for F-actin), COQ6 was 
expressed in spiral ganglion neurons in Rosenthal canal 
(arrowheads). (G) Higher-magnification view of boxed 
region in F showing COQ6 expression in stria vascularis 
cells (arrowheads) and the spiral ligament (arrow). Signal in 
tectorial membrane (tm) and adjacent structures most likely 
represents background staining. Rm, Reissner membrane; 
cd, cochlear duct; st, scala tympani; sv, scala vestibuli. In 
merged images, nuclei are stained blue with DAPI. Scale 
bars: 50 μm (A–E); 300 μm (F); 100 μm (G).
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COQ6 knockdown causes apoptosis in podocytes and zebrafish embryos. (A–C) Coq6 downregulation in cultured mouse podocytes induced 
apoptosis that was diminished by CoQ10 treatment. Data are mean ± SEM. (A) Growth curve analysis of Coq6 knockdown clones. 20,000 
podocytes were seeded per 24-well plate, plated, detached, and counted (n = 4). (B and C) Caspase-9 (B) and caspase-3 (C) activity in undif-
ferentiated Coq6 knockdown clones by FIENA before and after CoQ10 treatment. RFUs derived from cleaved capase-9 or caspase-3 sub-
strate peptide were measured in lysates from 1 × 106 cells (n = 3). C, control clone; No Tx, no treatment. *P < 0.001, †P < 0.05 versus control; 
#P < 0.005, ‡P < 0.05 versus untreated. (D–F) coq6 knockdown in zebrafish embryos 28 hours after fertilization increases apoptosis. (D) coq6-
MO4 directed against zebrafish coq6 intron 7 splice donor blocked proper splicing of coq6 mRNA (see Supplemental Figure 1N). Negative 
controls were injected with 0.1 mM coq6 mismatch MO. Note the gray appearance of zebrafish heads upon differential interference contrast 
(DIC) microscopy as a sign of increased cell death. (E and F) Zebrafish dorsal head and lateral trunk views. Embryos were injected as indicated 
with 0.1 mM coq6-MO4 splice targeting MO (E), MO targeting the AUG translation start site (dcoq6 MO1; F), coq6 mismatch (mm) MO nega-
tive controls, or left uninjected (WT). Cells were stained by an antibody against cleaved caspase-3, a specific marker for apoptotic cells. Lens 
(asterisk), yolk sac (ys), and cloaca (arrow) are indicated. Scale bars: 1 mm (D); 100 μm (E and F).
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alpha-actinin-4, cause familial focal segmental glo-
merulosclerosis. Nat Genet. 2000;24(3):251–256.
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